Anebulo Pharmaceuticals ANEB
OTC ANEB
$0.32 +0.00 (+0.00%)
At close: Sep 29, 2026 · 4:00 PM EDT

Anebulo Pharmaceuticals (ANEB) Invested Capital (2020)

Updated

Anebulo Pharmaceuticals' Invested Capital came in at $30,149 for fiscal Q4 2020 (quarter ended Jun 30, 2020).

Analysis

Anebulo Pharmaceuticals (ANEB) Invested Capital (2020) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Invested Cap. (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn 134.01 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn 64.89 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn 95.89 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn 79.44 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn 50.26 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn 68.99 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn 38.08 Bn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn 148.69 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn -
10 Anebulo Pharmaceuticals 13.15 Mn 13.15 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2020 30,149.00
API Access

Anebulo Pharmaceuticals Invested Capital API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=invested-capital&ticker=ANEB&period=max&api_key=YOUR_API_KEY